Literature DB >> 12138603

Issues in the approval of, access to, and post-marketing follow-up of new drugs in Canada: a personal viewpoint.

Nigel S B Rawson1.   

Abstract

Mesh：

Year:  2002        PMID： 12138603     DOI： 10.1002/pds.740

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  3 in total

1.  "Cost-effectiveness" estimates result in flawed decision-making in listing drugs for reimbursement.

Authors:  Roy West; E Keith Borden; Jean-Paul Collet; Nigel S B Rawson; Robert S Tonks
Journal:  Can J Public Health       Date:  2002 Nov-Dec

2.  Lessons for a national pharmaceuticals strategy in Canada from Australia and New Zealand.

Authors:  Jacques LeLorier; Nugek S B Rawson
Journal:  Can J Cardiol       Date:  2007-07       Impact factor: 5.223

3.  The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation.

Authors:  Michelle Sholzberg; Tara Gomes; David N Juurlink; Zhan Yao; Muhammad M Mamdani; Andreas Laupacis
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.